16 These changes may lower intraglomerular pressure and confer renal protection, with secondary benefits on BP control
When functioning properly, the gut barrier allows nutrients to pass while blocking harmful molecules
Many companies selling these medications have recently been issued warnings by the FDA for false advertising claims
Animal studies have shown that a combination of exercise and dietary modification results in an alteration of the intestinal microbiota, an increase in the production of intestinal mucins, and a reduction of endotoxin and inflammatory cytokine production, which in turn prevents the development of steatosis (74, 143, 282285)
Pascal Soriot, CEO of the company noted he was excited about the acceleration of the companys cardiometabolic and obesity pipeline with the licensing agreement for ECC5004, a potential best-in-class oral GLP-1RA. ECC5004 has an oral formulation, in contrast to Novo Nordisks Wegovy (semaglutide) and the recently approved Lillys Zepbound (tirzepatide), which are injectables
